Methicillin-susceptible Staphylococcus aureus (MSSA) strains can produce superantigenic toxins that may trigger a massive release of pro-inflammatory cytokines, which are involved in the onset of septic shock. This 1-year prospective pilot study assessed the role of the production of superantigenic toxins in the outcome of immunocompetent patients hospitalised for community-acquired MSSA bacteraemia. Thirty-seven patients were enrolled, of whom 14 died in hospital. Fourteen patients had septic shock, and the mortality rate in this subgroup was 56%. Twenty-seven (73%) isolates produced at least one superantigenic toxin, but this did not influence the rate of occurrence of septic shock or death. © 2007 The Authors Journal Compilation © 2007 European Society of Clinical Microbiology and Infectious Diseases.
CITATION STYLE
Desachy, A., Lina, G., Vignon, P., Hashemzadeh, A., Denis, F., Etienne, J., … Ploy, M. C. (2007). Role of superantigenic strains in the prognosis of community-acquired methicillin-susceptible Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection, 13(11), 1131–1133. https://doi.org/10.1111/j.1469-0691.2007.01810.x
Mendeley helps you to discover research relevant for your work.